| A nice short read on a PROTAC approach |
| @Mathewhewlett |
05/01/2023 12:22:38 AM |
| Its not about revenue. |
| @Jesus |
04/27/2023 7:20:11 PM |
| The stock has dropped from the .60 area |
| @fxm474 |
04/25/2023 2:14:15 PM |
| AML news. |
| @MJR4826 |
04/21/2023 5:09:01 PM |
| TP53 rules. |
| @chores63 |
04/20/2023 12:34:17 PM |
| Precipitation in stomach rules. |
| @Uniquify |
04/19/2023 11:35:52 PM |
| It is what it is. Another option. |
| @MrWalnuts |
04/19/2023 9:23:53 PM |
| Now they want you to vote for reverse |
| @ERRE |
04/19/2023 7:31:48 PM |
| Good day for biotech tomorrow? |
| @Rusty77 |
04/16/2023 9:28:41 PM |
| Thank you |
| @alexleesl85 |
04/14/2023 10:46:46 PM |
| There is a chance but you need a |
| @mikeloke |
04/14/2023 10:19:10 PM |
| Ok, thanks. How about the possibility to displace |
| @jnedelko |
04/14/2023 9:04:33 PM |
| Chance to be used after Gilteritinib? Sure. It |
| @Harkd |
04/14/2023 8:25:10 PM |
| Decaf, do you think TUSP really has a |
| @ChrisByrd |
04/14/2023 4:46:46 PM |
| Decaf, sounds like youre getting a bit more |
| @Bakakuma |
04/14/2023 3:23:18 PM |
| In addition, on Slide 12 you can see |
| @StoxPro |
04/14/2023 2:17:41 PM |
| A new redesigned Corporate presentation is available. |
| @Aspiangela |
04/14/2023 1:49:54 PM |
| It was accelerated approval. Doesn't count much. But |
| @Bentosmd |
04/10/2023 6:44:09 PM |
| Pirtobrutinib was approved for MCL in January. |
| @Esam2020 |
04/10/2023 5:35:47 PM |
| Possible reason for Zilo phase 3 trial termination? |
| @cers2019 |
04/07/2023 1:22:22 PM |
| Seems like a saga with naked ant-ROR1 antibody |
| @jdizzo8791 |
04/06/2023 10:48:14 PM |
| One additional risk shareholders have here is the |
| @lovebox |
04/06/2023 6:41:07 PM |
| Most of the market and analyst reports are |
| @RoamingBull |
04/05/2023 3:35:56 PM |
| Top 3 Canadian Pharma Stocks of 2023. |
| @DeepBlue |
04/05/2023 1:13:18 PM |
| They should execute on their own guidance. It |
| @LidiyaMartin |
03/31/2023 10:06:39 PM |
| If they are not slow walking Lux, what |
| @180stocks |
03/31/2023 7:46:56 PM |
| I'm more interested in them getting to the |
| @jcostello1975 |
03/31/2023 5:09:39 PM |
| In January Corporate presentation you can find, "1Q |
| @joshgfeller |
03/29/2023 5:08:22 PM |
| I think it will depend on how strong |
| @pERRY1234 |
03/29/2023 4:37:34 PM |
| ADMIRAL trial was Gilteritinib against salvage therapy in |
| @reamonpgh |
03/29/2023 4:30:52 PM |
| In the case of TUSP monotherapy I am |
| @Rico |
03/28/2023 3:01:49 PM |
| Im going to start praying to St. Jude, |
| @watjohn |
03/28/2023 12:28:40 PM |
| Would do cartwheels for $8/share |
| @haimkoskas |
03/28/2023 12:54:34 AM |
| Canaccord Genuity has decided to maintain its Buy |
| @clarice0906 |
03/27/2023 9:06:53 PM |
| It should affect Aptose. After that, don't think |
| @clarice0906 |
03/25/2023 1:34:23 PM |
| That's my point. The design and targets |
| @Zlatko |
03/24/2023 5:59:48 PM |
| Yes, unless they want to recruit Ven-naive patients. |
| @PENDAKE1 |
03/24/2023 5:21:45 PM |
| Getting a first look at the population that |
| @delmar65 |
03/24/2023 4:42:45 PM |
| As I previosly mentioned, Tusp/Ven trial won't be |
| @productsking |
03/24/2023 4:21:37 PM |
| I don't know how many sites are open |
| @royjame8765 |
03/24/2023 3:39:31 PM |
| Guy's, I know Tusp shows "promise", but this |
| @Av3ngeme |
03/24/2023 2:56:55 PM |
| I will listen to the call again today, |
| @birkspurr |
03/24/2023 2:18:46 PM |
| Was distracted yesterday by multiple tasks and could |
| @Dlarson |
03/24/2023 1:39:07 PM |
| OK, they said they treated 60 patients. Closest |
| @commapr |
03/24/2023 12:07:17 AM |
| I had no chance to listen to the |
| @Tryingtoretire |
03/23/2023 10:16:11 PM |
| $APTO Quarterly: |
| @LidiyaMartin |
03/23/2023 9:54:22 PM |
| Done deal. Biotech just dodged a huge bullet. |
| @meghat |
03/13/2023 12:10:49 AM |
| Totally agree. |
| @amitchate |
03/12/2023 10:16:15 PM |
| High probability that all depositors will be made |
| @Snooz1011 |
03/12/2023 9:44:40 PM |
| Well see. I want an update on |
| @PENDAKE1 |
03/12/2023 4:41:28 PM |
| znewcar1: $APTO 30% v3,6M c.718 f92,3M H.720 ML.4508 strong week |
| @MICHELHAK |
11/03/2022 8:19:27 PM |
| whytestocks: $APTO News Article - Aptose Clinical Data to be Presented at the 2022 ASH Annual Meeting |
| @ |
11/03/2022 2:30:50 PM |
| whytestocks: $APTO News Article - Aptose Reports Results for the Third Quarter 2022 |
| @ |
11/01/2022 8:05:51 PM |
| znewcar1: APTO LL.7731 @.836 |
| @cottle |
06/15/2022 7:06:55 PM |
| whytestocks: $APTO News Article - Aptose Reports Results for the Fourth Quarter and Full Year 2021 |
| @ |
03/22/2022 8:55:56 PM |
| whytestocks: $APTO News Article - Aptose Biosciences Climbs 17% to Reclaim Some Losses |
| @ |
12/16/2021 5:09:40 PM |
| znewcar1: APTO 66% v180M c6.10 f88,8M H7.2 gapNgo hit HOD in 30m then bounced off lower BB@5.5 interesting! |
| @Takuri33 |
03/24/2021 11:15:31 PM |
| whytestocks: $APTO News Article - Aptose Biosciences to Host Key Opinion Leader Event Present at BIO CEO & Invest |
| @ |
01/29/2020 1:20:43 PM |
| whytestocks: $APTO bulls and bears |
| @ |
12/30/2019 5:55:46 PM |
| whytestocks: $APTO News Article - Why Aptose Biosciences Shares Jumped Today |
| @ |
12/11/2019 9:45:42 PM |
| whytestocks: $APTO News Article - Small Molecule Oncology Drug Market Forecast To Exceed $66 Billion In 2019 |
| @ |
12/10/2019 1:35:43 PM |
| znewcar1: APTO 38% v10M c3.54 f55M H 3.97 Gap from 2.5ish to 3 then pulled hard HOD S@3.25 finished strong! ga |
| @NinjaHotdog |
12/09/2019 11:04:48 PM |
| whytestocks: $APTO News Article - Aptose Appoints Rafael Bejar, M.D., Ph.D., as Chief Medical Officer |
| @ |
12/04/2019 4:30:54 PM |
| whytestocks: $APTO News Article - Aptose To Release Third Quarter Ended September 30, 2019 Financial Results and |
| @ |
10/22/2019 4:25:42 PM |
| whytestocks: $APTO News Article - Aptose Biosciences to Present at Canaccord Genuity 39th Annual Growth Conferenc |
| @ |
07/30/2019 6:45:39 PM |
| whytestocks: $APTO News Article - Aptose to Present at the Jefferies 2019 Healthcare Conference |
| @ |
05/31/2019 2:05:42 PM |
| whytestocks: $APTO News Article - Aptose Announces Pricing of Public Offering of Common Shares |
| @ |
05/30/2019 1:15:40 PM |
| PoemStone: $APTO gaps & candles $2.50 |
| @cmainer |
01/20/2018 10:18:11 PM |